Literature DB >> 19185167

Induction chemoradiotherapy facilitates radical resection of T4 non-small cell lung cancer invading the spine.

Masaki Anraku1, Thomas K Waddell, Marc de Perrot, Stephen J Lewis, Andrew F Pierre, Gail E Darling, Michael R Johnston, Rebecca E Zener, Yoga R Rampersaud, Frances A Shepherd, Natasha Leighl, Andrea Bezjak, Alexander Y Sun, David M Hwang, Ming-Sound Tsao, Shaf Keshavjee.   

Abstract

OBJECTIVE: We evaluated the outcome, long-term results, and factors affecting outcome of induction chemoradiotherapy followed by surgical resection for T4 non-small cell lung cancer invading the spine.
METHODS: Retrospective analysis of 23 consecutive patients undergoing radical vertebral resection for non-small cell lung cancer invading the spine between 1996 and 2007 was performed. In most cases, induction chemoradiotherapy consisted of cisplatin and etoposide followed by 45 Gy of radiation. Surgical resection with vertebrectomy was performed en bloc in either a 1-stage or 2-stage operation. Survival was estimated by Kaplan-Meier techniques. The log-rank comparison was used to compare groups.
RESULTS: There were 13 men and 10 women with a median age of 61 years (range 32-75). Twenty-two patients had induction chemoradiotherapy and 1 had induction chemotherapy alone. Vertebral resections included 6 total vertebrectomies, 15 hemivertebrectomies, and 2 partial vertebrectomies. Complete resection was achieved in 19 (83%) patients. Two (8.7%) patients died postoperatively. Pathologic complete response was observed in 10 (43%) patients. The 3-year survival was 58% (median follow-up, 34 months). Patients who achieved pathologic complete response or near complete response (viable tumor cells < 1%) demonstrated significantly better survival than those who did not (3-year survival, 92% vs 20%; P = .006).
CONCLUSION: Highly selected patients with lung cancer invading the spine can potentially be cured with induction chemoradiation therapy followed by radical en bloc resection of the tumor. A multidisciplinary operative strategy allows a significant chance of achieving complete resection in patients requiring multilevel hemivertebrectomy or total vertebrectomy and an appreciable cure rate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19185167     DOI: 10.1016/j.jtcvs.2008.09.035

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  One-stage surgery in combination with thoracic endovascular grafting and resection of T4 lung cancer invading the thoracic aorta and spine.

Authors:  Seijiro Sato; Tatsuya Goto; Terumoto Koike; Takeshi Okamoto; Hirokazu Shoji; Masayuki Ohashi; Kei Watanabe; Masanori Tsuchida
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

2.  Chest wall resection and reconstruction for lung cancer: surgical techniques and example of integrated multimodality approach.

Authors:  Mauro Loi; Antonio Mazzella; Isacco Desideri; Ludovic Fournel; Emelyne Canny Hamelin; Philippe Icard; Antonio Bobbio; Marco Alifano
Journal:  J Thorac Dis       Date:  2020-01       Impact factor: 2.895

3.  Initial extended resection or neoadjuvant therapy for T4 non-small cell lung cancer-What is the evidence?

Authors:  Ilkka Ilonen; David R Jones
Journal:  Shanghai Chest       Date:  2018-10-11

4.  Combined video-assisted thoracoscopy surgery and posterior midline incision for en bloc resection of non-small-cell lung cancer invading the spine.

Authors:  Kheira Hireche; Mathieu Moqaddam; Nicolas Lonjon; Charles Marty-Ané; Laurence Solovei; Baris Ata Ozdemir; Ludovic Canaud; Pierre Alric
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-30

5.  Evolution of the Surgical Management of Lung Cancer Invading the Spine: A Single Center Experience.

Authors:  Gabrielle Drevet; Théo Broussolle; Yanis Belaroussi; Lucie Duponchelle; Jean Michel Maury; Renaud Grima; Gualter Vaz; Clément Silvestre; François Tronc
Journal:  Curr Oncol       Date:  2022-04-26       Impact factor: 3.109

Review 6.  Surgical management of locally advanced lung cancer.

Authors:  Kohei Yokoi; Tetsuo Taniguchi; Noriyasu Usami; Koji Kawaguchi; Takayuki Fukui; Futoshi Ishiguro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-29

7.  Knockdown of CENPF inhibits the progression of lung adenocarcinoma mediated by ERβ2/5 pathway.

Authors:  Tang Hexiao; Bai Yuquan; Xiong Lecai; Wei Yanhong; Shen Li; Hu Weidong; Xu Ming; Zhou Xuefeng; Pan Gaofeng; Zhang Li; Zhu Minglin; Tang Zheng; Yang Zetian; Zhou Xiao; Cai Yi; Michael Lanuti; Zhao Jinping
Journal:  Aging (Albany NY)       Date:  2021-01-10       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.